When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OPNT - Opiant Pharmaceuticals EPS beats by $0.35 beats on revenue
Opiant Pharmaceuticals Inc.
Opiant Pharmaceuticals (NASDAQ:OPNT): Q3 GAAP EPS of $0.56 beats by $0.35. Revenue of $16.34M (+79.4% Y/Y) beats by $4.21M. Press Release Raises full-year 2021 revenue and cash guidance Royalty revenue from the sale of NARCAN Nasal Spray now anticipated to be approximately $38 million. Cash, cash equivalents and marketable securities now expected to be in the range of approximately $50 million to $52 million, an increase of approximately $8 million greater than 2nd quarter guidance